Loading Events

« All Events

  • This event has passed.

Acceleration2015: Nutter Early Stage Life Sciences Conference

November 11, 2015 @ 3:00 pm - 7:00 pm

Acceleration2015: Nutter Early Stage Life Sciences Conference – connecting investors, entrepreneurs and industry executives in biotechnology, pharmaceuticals, medical devices, and health IT who are focused on growth. Join key thought leaders to examine the best paths to success in an active yet volatile market.  An outstanding line-up of speakers is coming together for this conference to discuss current issues and trends in early-stage development among life science companies.

Omar Amirana, MD
Senior Vice President I Allied Minds

Panel I:   Drugs, Devices and Diagnostics: Will the IPOs, M&As and investments continue?

  • Ben Dunn, Managing Director | Covington Associates
  • Bryan Giraudo, Managing Director | Leerink Partners
  • Paulina Hill, Principal | Polaris Partners
  • James Woods, Principal – Deals, Valuation, PwC
  • Moderator – Luke Timmerman, Founder & Editor l Timmerman Report

Panel II: Market Viability: What are the prerequisites for success?

  • PJ Anand, Founder, President & CEO | Alcyone Lifesciences
  • Luba Greenwood, Vice President, Global M&A and Business Development | F. Hoffmann-La Roche Diagnostics
  • Jason Hafler, Senior Director of Investments and Principal | Sanofi-Genzyme BioVentures
  • Moderator – Jeremy Halpern, Partner, Emerging Companies | Nutter

Who should attend?

  • Founders, executives and board members of early stage life sciences companies
  • Angel investors
  • Venture Capital investors
  • Corporate venture investors
  • Private foundation investors
  • Pharmaceutical and biotechnology business development executives
  • University/Research Technology Licensing Officers


November 11, 2015
3:00 pm - 7:00 pm


Nutter McClennen & Fish
155 Seaport Boulevard, Seaport West
Boston,MA02210United States
+ Google Map

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow us!

Send this to a friend